New FP7 eHealth Project - COMOESTAS

COMOESTAS aims to develop an innovative ICT system that allows patients with Medication Overuse Headache (MOH), a common condition and a major cause of disability, to receive continuous and personalised treatment. The system will be based on an advanced Alerting and Decision Support System that follows patients from the diagnosis and supports the physician in managing the therapy, controlling relevant events impacting on patient safety.

Medication Overuse Headache (MOH) results from the chronicisation of primary forms of headaches, as a consequence of the progressive increase in the intake of symptomatic drugs. The first choice treatment for MOH is the withdrawal of the overused medication(s) (detoxification), which is preferentially done by hospitalising the patients. Even if most patients improve as a result of detoxification, up to 45% of patients relapse, reverting to the overuse of symptomatic drugs.

Paper diaries and calendars for recording headache attacks have long been used in the clinical practice for the management of headache patients. Isolated attempts to electronically record headache attacks have also been performed, based on the use of single common files.

At present, however, there is no scientifically validated informative tool that could manage patient's treatment, from the first observation to the whole follow-up. The availability of such a tool would grant an innovative approach to MOH.

Objectives of the project and project description
The general objective of the COMOESTAS project is to improve and integrate the management of MOH with an innovative electronic tool that makes the patient himself a key node in the treatment process. The new system, will be based on a complex informative system called Interactive Electronic Patient Record (IEPR) and will constitute an "all-inone" solution that will allow constant monitoring of the clinical condition of the patient by the doctor and provide a system of alerts and warnings should selected parameters exceed given thresholds. The system will also be designed in order to improve the patientdoctor communication.

Expected Results and Impacts
The constant monitoring by means of the electronic diary and programmed or alertprompted follow-up visits permit and favour a better interaction between patient and physician in order to ameliorate the management of these patients after the withdrawal. Furthermore, this will increase patient safety by optimising medical interventions, preventing errors and reducing drug-induced side effects (i.e. gastritis, hypertension). As a consequence, direct (consultations, hospitalisations, etc.) and indirect (i.e. linked to the disability and complications caused by the disease) costs provoked by the condition will be reduced.

Work in progress

  • The kick-off meeting took place in Pavia, on February 14-16
  • Indicators, clinical protocol and clinical tools have been devised, and will be finalised in April
  • The beta version of the IEPR system will be ready for pilot testing by the end of May
  • Clinical centres in Argentina and Chile are collecting data on the epidemiological impact of MOH in Latin America

For further information, please visit:
http://www.comoestas-project.eu

Related article:

Most Popular Now

AI-Powered CRISPR could Lead to Faster G…

Stanford Medicine researchers have developed an artificial intelligence (AI) tool to help scientists better plan gene-editing experiments. The technology, CRISPR-GPT, acts as a gene-editing “copilot” supported by AI to help...

Groundbreaking AI Aims to Speed Lifesavi…

To solve a problem, we have to see it clearly. Whether it’s an infection by a novel virus or memory-stealing plaques forming in the brains of Alzheimer’s patients, visualizing disease processes...

ChatGPT 4o Therapeutic Chatbot 'Ama…

One of the first randomized controlled trials assessing the effectiveness of a large language model (LLM) chatbot 'Amanda' for relationship support shows that a single session of chatbot therapy...

AI Tools Help Predict Severe Asthma Risk…

Mayo Clinic researchers have developed artificial intelligence (AI) tools that help identify which children with asthma face the highest risk of serious asthma exacerbation and acute respiratory infections. The study...

AI Model Forecasts Disease Risk Decades …

Imagine a future where your medical history could help predict what health conditions you might face in the next two decades. Researchers have developed a generative AI model that uses...

AI Distinguishes Glioblastoma from Look-…

A Harvard Medical School–led research team has developed an AI tool that can reliably tell apart two look-alike cancers found in the brain but with different origins, behaviors, and treatments. The...

Smart Device Uses AI and Bioelectronics …

As a wound heals, it goes through several stages: clotting to stop bleeding, immune system response, scabbing, and scarring. A wearable device called "a-Heal," designed by engineers at the University...

AI Model Indicates Four out of Ten Breas…

A project at Lund University in Sweden has trained an AI model to identify breast cancer patients who could be spared from axillary surgery. The model analyses previously unutilised information...

Overcoming the AI Applicability Crisis a…

Opinion Article by Harry Lykostratis, Chief Executive, Open Medical. The government’s 10 Year Health Plan makes a lot of the potential of AI-software to support clinical decision making, improve productivity, and...

Dartford and Gravesham Implements Clinis…

Dartford and Gravesham NHS Trust has taken a significant step towards a more digital future by rolling out electronic test ordering using Clinisys ICE. The trust deployed the order communications...